- Type 2 DM:
- PO 5mg OD
Tablet: 5mg
Administered without regard to food
Dipeptidyl peptidase 4 (DPP-4) inhibitor
It inhibits dipeptidyl peptidase-4, slowing incretin metabolism, increasing insulin synthesis/release thereby decreasing glucagon levels
- Nasopharyngitis
- Hypoglycemia
- Diarrhea
- Hyperuricemia
- Hyperlipasemia
- Cough
- Hypersensitivity
- Type 1 DM
- Diabetic ketoacidosis
None restricted
Drug Status
| Availability | Prescription only |
| Pregnancy | Category B; Use only when needed |
| Breastfeeding | Consider alternative |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Lina | 5mg | Tablet | 30’s | CCL Pharma | Harley’s Ltd |
| Linaglipt | 5mg | Tablet | 30’s | Galaxy Pharma | Galaxy Pharma |
| Linvesta | 10mg | Tablet | 10’s | Q Pharma DMCC | Cintana Healthcare |
| Trajenta | 5mg | Tablet | 30’s | Boehringer Ingelheim | Surgipharm Ltd |